Medicare Advantage (MA) trends continue to show more promising avenues for reimbursement as expansion continues. Coding multiple diagnoses for one[…]
Read moreLatest Posts
Market Access Support for 2 Biologic Technologies Results in a Medical Coverage Policy, Benefits 8 Million Federal Employees
The GIRS Payer Advocacy® (PAC) team began working with a key payer in 2013 on coverage and payment after our[…]
Read morePayer Interest Grows as Medicare Advantage Enrollment Continues to Increase, Showing Signs of a Stable Market
Medicare beneficiaries can elect to have their healthcare coverage administered either through traditional Medicare (also referred to as Original Medicare)[…]
Read moreFDA Launches Complex Innovative Designs Pilot Meeting Program in Effort to Advance Clinical Trials of Drugs and Biologics
August 29, the U.S. Food and Drug Administration announced a new program, Complex Innovative Designs Pilot Meeting Program or CIDPMP. […]
Read more
GIRS Successfully Assists with the Overturning of Claims Denials
A provider contacted the GIRS InContact Reimbursement Hotline® team for assistance with a denial of a claim. After collecting the[…]
Read morePayer Advocacy Efforts Enabled Improved Patient Access to a Breakthrough Medical Device for Potentially 3.7 Million Patients in the Mid-South
The GIRS Payer Advocacy® (PAC) team began working with a key payer in February 2018 for coverage and payment information[…]
Read moreThe GIRS PAC® Team Overturns Long-term Negative Coverage for a Breakthrough Biologic in a Key Payer Market.
The GIRS Payer Advocacy® (PAC) Team began working with a key regional payer in June 2015 to advocate for coverage[…]
Read moreGIRS Successfully Educates a Key East Coast Insurer on the Value Proposition of a Breakthrough Medical Device
The GIRS Payer Advocacy® (PAC) Team began working with a key regional payer in June 2018 to assist with the[…]
Read moreGIRS Integrated Hotline Solutions Resolves Medical Device Pricing Issue
A provider contacted the GIRS InContact Reimbursement Hotline® when he received a lower than expected reimbursement from a private payer[…]
Read moreGIRS Ensures Market Access for a Breakthrough Medical Device for Approximately 3 million Covered Lives in the Southeast.
The GIRS Payer Advocacy® (PAC) Team began working with a key regional payer in April 2018 to assist with the[…]
Read more